Manufacturers Life Insurance Company, The Kala Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.62 - $5.43 $79,619 - $165,012	-30,389 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.06 - $8.15 $27,617 - $44,482	5,458 Added 21.89%	30,389 $161,000
Q1 2021 May 03, 2021	SELL	$6.24 - $9.58 $4,212 - $6,466	-675 Reduced 2.64%	24,931 $168,000
Q4 2020 Feb 12, 2021	BUY	$6.28 - $8.79 $11,373 - $15,918	1,811 Added 7.61%	25,606 $174,000
Q2 2020 Aug 10, 2020	BUY	$8.33 - $13.79 $77,602 - $128,467	9,316 Added 64.34%	23,795 $244,000
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $55,454 - $127,270	14,479 New	14,479 $127,000
Q3 2018 Nov 14, 2018	SELL	$9.54 - $13.87 $7,250 - $10,541	-760 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.49 $146,539 - $192,704	-11,018 Reduced 93.55%	760 $10,000
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $119,915 - $185,643	9,781 Added 489.78%	11,778 $186,000
Q4 2017 Feb 08, 2018	SELL	$13.68 - $23.17 $59,549 - $100,859	-4,353 Reduced 68.55%	1,997 $36,000
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $126,111 - $168,465	6,350	6,350 $145,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.05M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.